Skip to content

Rock Springs Capital Management LP 13F Holdings · Q2 2026

Rock Springs Capital Management LP reported 104 securities worth $2.05B in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: RVMD (10.10%), TVTX (6.04%), LLY (5.78%). Among its top 25 positions this quarter: 1 new, 10 added, 12 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1RVMDREVOLUTION MEDICINES INC$207.0M10.10%1.1MTrimmed
2TVTXTRAVERE THERAPEUTICS INC$123.8M6.04%2.2MAdded
3LLYELI LILLY & CO$118.4M5.78%98,700Hold
4MDGLMADRIGAL PHARMACEUTICALS INC$94.0M4.59%174,999Added
5MIRMMIRUM PHARMACEUTICALS INC$93.4M4.56%798,145Trimmed
6RYTMRHYTHM PHARMACEUTICALS INC$76.9M3.75%692,598Added
7KYMRKYMERA THERAPEUTICS INC$52.0M2.54%453,156Trimmed
8ARGXARGENX SE$48.9M2.39%52,750Trimmed
9ASNDASCENDIS PHARMA A/S$45.0M2.20%168,750New
10XENEXENON PHARMACEUTICALS INC$41.3M2.01%683,907Trimmed
11SRRKSCHOLAR ROCK HLDG CORP$39.3M1.92%715,452Trimmed
12INSMINSMED INC$38.6M1.88%362,150Added
13PENPENUMBRA INC$36.5M1.78%115,750Trimmed
14GPCRSTRUCTURE THERAPEUTICS INC$34.4M1.68%640,317Added
15RAREULTRAGENYX PHARMACEUTICAL IN$32.3M1.58%967,855Trimmed
16IRTCIRHYTHM HOLDINGS INC$32.1M1.57%269,650Added
17ISRGINTUITIVE SURGICAL INC$30.4M1.48%76,460Trimmed
18AGLAGILON HEALTH INC$28.1M1.37%262,600Added
19UNHUNITEDHEALTH GROUP INC$26.5M1.29%63,750Added
20CLDXCELLDEX THERAPEUTICS INC NEW$26.0M1.27%699,146Added
21ERASERASCA INC$25.7M1.25%1.4MAdded
22NBIXNEUROCRINE BIOSCIENCES INC$24.4M1.19%144,750Trimmed
23ELVNENLIVEN THERAPEUTICS INC$23.6M1.15%464,625Trimmed
24THCTENET HEALTHCARE CORP$23.4M1.14%125,000Hold
25DXCMDEXCOM INC$23.1M1.13%343,000Trimmed

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR